Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6750 | 1448 | 28.3 | 45% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
522 | 3 | MAGNESIUM-BULLETIN//MAGNESIUM RESEARCH//MAGNESIUM | 20526 |
2418 | 2 | HYDROCHLOROTHIAZIDE//CICLETANINE//TORASEMIDE | 4143 |
6750 | 1 | TORASEMIDE//LOOP DIURETICS//FUROSEMIDE | 1448 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TORASEMIDE | authKW | 850429 | 5% | 61% | 66 |
2 | LOOP DIURETICS | authKW | 347825 | 5% | 25% | 66 |
3 | FUROSEMIDE | authKW | 295138 | 9% | 11% | 129 |
4 | TORSEMIDE | authKW | 121540 | 1% | 41% | 14 |
5 | DIURETIC RESISTANCE | authKW | 103119 | 1% | 33% | 15 |
6 | DIURETICS | authKW | 83240 | 6% | 5% | 84 |
7 | FRUSEMIDE | authKW | 79638 | 2% | 16% | 23 |
8 | BEMETIZIDE | authKW | 63259 | 0% | 100% | 3 |
9 | SEGMENTAL NEPHRON BLOCKADE | authKW | 63259 | 0% | 100% | 3 |
10 | XIPAMIDE | authKW | 58386 | 0% | 46% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 11736 | 52% | 0% | 758 |
2 | Urology & Nephrology | 1284 | 9% | 0% | 135 |
3 | Cardiac & Cardiovascular System | 1136 | 12% | 0% | 175 |
4 | Medicine, General & Internal | 938 | 13% | 0% | 190 |
5 | Medicine, Research & Experimental | 510 | 8% | 0% | 117 |
6 | Chemistry, Medicinal | 276 | 5% | 0% | 70 |
7 | Toxicology | 76 | 3% | 0% | 43 |
8 | Peripheral Vascular Diseases | 76 | 3% | 0% | 42 |
9 | Critical Care Medicine | 64 | 2% | 0% | 24 |
10 | Physiology | 51 | 3% | 0% | 45 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ABT INNERE MED CRIT CARE | 21086 | 0% | 100% | 1 |
2 | AC PROGRAM CARDIOL | 21086 | 0% | 100% | 1 |
3 | ARTZ KLIN PHARMAKOL SPORTMED | 21086 | 0% | 100% | 1 |
4 | BI OURCE SCI | 21086 | 0% | 100% | 1 |
5 | CARITAS KRANKEHAUS | 21086 | 0% | 100% | 1 |
6 | CHAIR CARDIOL 1ST | 21086 | 0% | 100% | 1 |
7 | ENDOTHELIAL FUNCT UNIT | 21086 | 0% | 100% | 1 |
8 | GUIPUZOCA POLICLIN | 21086 | 0% | 100% | 1 |
9 | HBIOL TOXIKOL | 21086 | 0% | 100% | 1 |
10 | HEART FAILURE CARDIOMYOPATHY PROGRAM | 21086 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 19118 | 5% | 1% | 66 |
2 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 14549 | 5% | 1% | 70 |
3 | NIEREN-UND HOCHDRUCKKRANKHEITEN | 10677 | 2% | 2% | 22 |
4 | JOURNAL OF CLINICAL PHARMACOLOGY | 8158 | 3% | 1% | 46 |
5 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 7938 | 3% | 1% | 47 |
6 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 6516 | 3% | 1% | 37 |
7 | PHARMATHERAPEUTICA | 4269 | 1% | 3% | 8 |
8 | ZEITSCHRIFT FUR KARDIOLOGIE | 3492 | 2% | 1% | 26 |
9 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2954 | 2% | 0% | 34 |
10 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 2827 | 2% | 1% | 23 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TORASEMIDE | 850429 | 5% | 61% | 66 | Search TORASEMIDE | Search TORASEMIDE |
2 | LOOP DIURETICS | 347825 | 5% | 25% | 66 | Search LOOP+DIURETICS | Search LOOP+DIURETICS |
3 | FUROSEMIDE | 295138 | 9% | 11% | 129 | Search FUROSEMIDE | Search FUROSEMIDE |
4 | TORSEMIDE | 121540 | 1% | 41% | 14 | Search TORSEMIDE | Search TORSEMIDE |
5 | DIURETIC RESISTANCE | 103119 | 1% | 33% | 15 | Search DIURETIC+RESISTANCE | Search DIURETIC+RESISTANCE |
6 | DIURETICS | 83240 | 6% | 5% | 84 | Search DIURETICS | Search DIURETICS |
7 | FRUSEMIDE | 79638 | 2% | 16% | 23 | Search FRUSEMIDE | Search FRUSEMIDE |
8 | BEMETIZIDE | 63259 | 0% | 100% | 3 | Search BEMETIZIDE | Search BEMETIZIDE |
9 | SEGMENTAL NEPHRON BLOCKADE | 63259 | 0% | 100% | 3 | Search SEGMENTAL+NEPHRON+BLOCKADE | Search SEGMENTAL+NEPHRON+BLOCKADE |
10 | XIPAMIDE | 58386 | 0% | 46% | 6 | Search XIPAMIDE | Search XIPAMIDE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BRATER, DC , (2011) UPDATE IN DIURETIC THERAPY: CLINICAL PHARMACOLOGY.SEMINARS IN NEPHROLOGY. VOL. 31. ISSUE 6. P. 483 -494 | 49 | 70% | 12 |
2 | PONTO, LLB , SCHOENWALD, RD , (1990) FUROSEMIDE (FRUSEMIDE) - A PHARMACOKINETIC PHARMACODYNAMIC REVIEW .2..CLINICAL PHARMACOKINETICS. VOL. 18. ISSUE 6. P. 460-471 | 82 | 77% | 41 |
3 | HAMMARLUNDUDENAES, M , BENET, LZ , (1989) FUROSEMIDE PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTH AND DISEASE - AN UPDATE.JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS. VOL. 17. ISSUE 1. P. 1-46 | 67 | 91% | 90 |
4 | SHANKAR, SS , BRATER, DC , (2003) LOOP DIURETICS: FROM THE NA-K-2CL TRANSPORTER TO CLINICAL USE.AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY. VOL. 284. ISSUE 1. P. F11 -F21 | 56 | 67% | 53 |
5 | BRATER, DC , (1998) DIURETIC THERAPY.NEW ENGLAND JOURNAL OF MEDICINE. VOL. 339. ISSUE 6. P. 387 -395 | 46 | 74% | 248 |
6 | EADES, SK , CHRISTENSEN, ML , (1998) THE CLINICAL PHARMACOLOGY OF LOOP DIURETICS IN THE PEDIATRIC PATIENT.PEDIATRIC NEPHROLOGY. VOL. 12. ISSUE 7. P. 603-616 | 59 | 61% | 30 |
7 | VREE, TB , VAN DER VEN, AJAM , (1999) CLINICAL CONSEQUENCES OF THE BIPHASIC ELIMINATION KINETICS FOR THE DIURETIC EFFECT OF FUROSEMIDE AND ITS ACYL GLUCURONIDE IN HUMANS.JOURNAL OF PHARMACY AND PHARMACOLOGY. VOL. 51. ISSUE 3. P. 239 -248 | 45 | 79% | 14 |
8 | DUNN, CJ , FITTON, A , BROGDEN, RN , (1995) TORASEMIDE - AN UPDATE OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY.DRUGS. VOL. 49. ISSUE 1. P. 121-142 | 44 | 83% | 63 |
9 | WARGO, KA , BANTA, WM , (2009) A COMPREHENSIVE REVIEW OF THE LOOP DIURETICS: SHOULD FUROSEMIDE BE FIRST LINE?.ANNALS OF PHARMACOTHERAPY. VOL. 43. ISSUE 11. P. 1836-1847 | 23 | 96% | 33 |
10 | SICA, DA , GEHR, TWB , (1996) DIURETIC COMBINATIONS IN REFRACTORY OEDEMA STATES - PHARMACOKINETIC PHARMACODYNAMIC RELATIONSHIPS.CLINICAL PHARMACOKINETICS. VOL. 30. ISSUE 3. P. 229-249 | 47 | 70% | 44 |
Classes with closest relation at Level 1 |